METHOD OF DETERMINING PANCREATIC DISEASE

A method of determining pancreatic disease of the present invention is a method of determining whether an IPMN patient has pancreatic disease, the method including: a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining the IPMN pat...

Full description

Saved in:
Bibliographic Details
Main Authors NAKATA Mari, SANUKI Hiromi, TAKEYAMA Tetsuhide
Format Patent
LanguageEnglish
Published 04.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method of determining pancreatic disease of the present invention is a method of determining whether an IPMN patient has pancreatic disease, the method including: a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining the IPMN patient is a malignant IPMN patient or a pancreatic cancer patient when the concentration of the S100P is equal to or greater than a predetermined cutoff value, and the IPMN patient is a benign IPMN patient when the concentration of the S100P is smaller than the predetermined cutoff value.
Bibliography:Application Number: US201715404861